Evidence map›Paper›PMID 27409510›Full record

ArticleInvestigative ophthalmology & visual science2016

Visible-Light Optical Coherence Tomography Angiography for Monitoring Laser-Induced Choroidal Neovascularization in Mice.

Ronil S Shah, Brian T Soetikno, Ji Yi, Wenzhong Liu, Dimitra Skondra, Hao F Zhang, Amani A Fawzi

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Advances in Retinal Oximetry.Translational vision science & technology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Volumetric fluorescence retinal imagingBiomedical optics express · 2018
    Article
  18. Visible-light optical coherence tomography: a review.Journal of biomedical optics · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ronil S ShahDepartment of Ophthalmology Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Brian T SoetiknoDepartment of Ophthalmology Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States 2Functional Optical Imaging Laboratory, Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States 3Med.
Ji YiFunctional Optical Imaging Laboratory, Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States.
Wenzhong LiuFunctional Optical Imaging Laboratory, Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States.
Dimitra SkondraDepartment of Ophthalmology Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Hao F ZhangDepartment of Ophthalmology Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States 2Functional Optical Imaging Laboratory, Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, United States.
Amani A FawziDepartment of Ophthalmology Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
Novel Antiangiogenic Peptides for Treatment of Exudative AMDR24EY022883 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2013 to 2017
$6.2M
Multimodal Retinal Functional Imaging for Diabetic RetinopathyR01EY019951 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FAWZI, AMANI A, JIAO, SHULIANG · 2011 to 2015
$3.0M
Functional Retinal Imaging to Monitor Pharmaco-Therapies in Diabetic RetinopathyDP3DK108248 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FAWZI, AMANI A, ZHANG, HAO F · 2015 to 2015
$1.9M
Howard Hughes Medical InstituteNEI NIH HHS R01 EY019951NEI NIH HHS R24 EY022883NIDDK NIH HHS DP3 DK108248NIGMS NIH HHS T32 GM008152
6 · The paper itself

Abstract

purposeThis study sought to determine the earliest time-point at which evidence of choroidal neovascularization (CNV) could be detected with visible-light optical coherence tomography angiography (vis-OCTA) in a mouse model of laser-induced CNV.

methodsVisible light-OCTA was used to study laser-induced CNV at different time-points after laser injury to monitor CNV development and measure CNV lesion size. Measurements obtained from vis-OCTA angiograms were compared with histopathologic measurements from isolectin-stained choroidal flatmounts.

resultsChoroidal neovascularization area measurements between the vis-OCTA system and isolectin-stained choroidal flatmounts were significantly different in area for days 2 to 4 postlaser injury, and were not significantly different in area for days 5, 7, and 14. Choroidal neovascularization area measurements taken from the stained flatmounts were larger than their vis-OCTA counterparts for all time-points. Both modalities showed a similar trend of CNV size increasing from the day of laser injury until a peak of day 7 postlaser injury and subsequently decreasing by day 14.

conclusionsThe earliest vis-OCTA can detect the presence of aberrant vessels in a mouse laser-induced CNV model is 5 days after laser injury. Visible light-OCTA was able to visualize the maximum of the CNV network 7 days postlaser injury, in accordance with choroidal flatmount immunostaining. Visible light-OCTA is a reliable tool in both detecting the presence of CNV development, as well as accurately determining the size of the lesion in a mouse laser-induced CNV model.

Indexed as

LightAnimalsChoroidChoroidal NeovascularizationDisease Models, AnimalFluorescein AngiographyFundus OculiLaser CoagulationMiceMice, Inbred C57BLTomography, Optical Coherence

Identifiers

PMID27409510
PMCPMC4968775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.